Comprehensive analysis across mammalian tissues and cells decipher the underlying mechanism of m6A specificity

Abstract

N6-methyladenine (m6A) stands out as the most prevalent internal chemical modification on mammalian mRNA, playing a vital role in diverse biological processes. Despite considerable advancements in individual cell line studies, the characteristics of m6A sites across distinct cell lines or tissues remain elusive. In this study, we have successfully identified approximately 1.5 million high-confidence m6A sites in human and mouse cell lines or tissues using published m6A-seq data. By categorizing m6A sites into different consistency levels, we observe that those of high consistency are notably enriched near the stop codon. Furthermore, they exhibit a higher likelihood of interaction with known m6A binding proteins such as YTHDF1-3, RBM15, YTHDC1, and IGF2BP1, thereby influencing gene expression homeostasis. Additionally, these sites display a higher CpG density in the promoter region of the genes they mark, with METTL3 demonstrating a preference for binding to the promoter region of its marked genes. m6A sites of low consistency levels, including unique m6A sites, show a significant enrichment near the start codon. These sites are more prone to binding by newly discovered m6A-binding proteins such as DDX3X, PRPF8, and EIF3G. The identification of these distinct features of m6A sites lays a foundational understanding for unraveling the functional roles of m6A.